You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
GOA Therapeutics has raised $15.5 million in funding to unveil GOA26, a drug candidate aimed at addressing acute alcohol intoxication and poisoning.
PRIVATESep 17, 2026•about 2 hours ago
Amount Raised
$15.5 Million
Round Type
Venture - Series Unknown
West Palm BeachOther
Description
GOA Therapeutics Corporation presented IND-enabling preclinical findings for its lead drug candidate, GOA26, designed to rapidly lower BAC in cases of alcohol intoxication. The company aims to address a significant unmet medical need with this intervention. The funding will support further development of this innovative treatment. GOA26 is crucial for improving outcomes in emergency situations related to alcohol consumption.
Company Information
Company
GOA Therapeutics
Location
515 North Flagler Drive
West Palm Beach, Florida, United States
Don't miss GOA Therapeutics's next move
Get an email the moment GOA Therapeutics raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for GOA Therapeutics's next move